•
Jun 30, 2021

Selecta Biosciences Q2 2021 Earnings Report

Expected Revenue:$6.24M
-66.7% YoY
Expected EPS:-$0.12
1100.0% YoY
Total Revenue
$19.7M
0
EPS
$0
Previous year: -$0.25
-100.0%
Gross Profit
$19.7M
Cash and Equivalents
$126M
Previous year: $59.7M
+110.5%
Free Cash Flow
-$6.66M
Previous year: -$12M
-44.5%
Total Assets
$181M
Previous year: $75.2M
+140.0%

Selecta Biosciences

Selecta Biosciences